Laddar...
Targeting Breast Carcinoma with Radioiodinated Anti-HER2 Nanobody
INTRODUCTION: With a molecular weight an order of magnitude lower than antibodies but possessing comparable affinities, Nanobodies (Nbs) are attractive as targeting agents for cancer diagnosis and therapy. An anti-HER2 Nb could be utilized to determine HER2 status in breast cancer patients prior to...
Sparad:
| Huvudupphovsmän: | , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2012
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3551612/ https://ncbi.nlm.nih.gov/pubmed/23159171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nucmedbio.2012.08.008 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|